第一单位：
Tumour Suppression Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.;Cellular Plasticity and Disease Group, Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
作者：
Cian J,Lynch [1]
;
Raquel,Bernad [1]
;
Ana,Martínez-Val [2]
;
Marta N,Shahbazi [3]
;
Sandrina,Nóbrega-Pereira [4]
;
Isabel,Calvo [1]
;
Carmen,Blanco-Aparicio [5]
;
Carolina,Tarantino [6]
;
Elena,Garreta [6]
;
Laia,Richart-Ginés [7]
;
Noelia,Alcazar [1]
;
Osvaldo,Graña-Castro [8]
;
Gonzalo,Gómez-Lopez [8]
;
Irene,Aksoy [9]
;
Maribel,Muñoz-Martín [1]
;
Sonia,Martinez [5]
;
Sagrario,Ortega [10]
;
Susana,Prieto [11]
;
Elisabeth,Simboeck [11]
;
Alain,Camasses [11]
;
Camille,Stephan-Otto Attolini [12]
;
Agustin F,Fernandez [13]
;
Marta I,Sierra [13]
;
Mario F,Fraga [13]
;
Joaquin,Pastor [5]
;
Daniel,Fisher [11]
;
Nuria,Montserrat [14]
;
Pierre,Savatier [9]
;
Javier,Muñoz [2]
;
Magdalena,Zernicka-Goetz [15]
;
Manuel,Serrano [16]
作者单位：
Tumour Suppression Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.;Cellular Plasticity and Disease Group, Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
[1]
ProteoRed-ISCIII Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
[2]
Mammalian Embryo and Stem Cell Group, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.;MRC Laboratory of Molecular Biology, Biomedical Campus, Cambridge, UK.
[3]
Department of Medical Sciences and Institute of Biomedicine (iBiMED), University of Aveiro, Aveiro, Portugal.
[4]
Experimental Therapeutics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
[5]
Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Barcelona, Spain.
[6]
Maintenance of Transcriptional Repression by Polycomb Proteins, Institut Curie, Paris, France.
[7]
Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
[8]
Stem Cell and Brain Research Institute, Univ Lyon, Université Lyon 1, INSERM U1208, Bron, France.
[9]
Transgenic Mice Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
[10]
IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France.
[11]
Bioinformatics-Biostatistics Unit, Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
[12]
Cancer Epigenetics and Nanomedicine Laboratory, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain.
[13]
Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Barcelona, Spain.;Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina, Barcelona, Spain.;Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
[14]
Mammalian Embryo and Stem Cell Group, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.;Division of Biology and Biological Engineering, Caltech, Pasadena, CA, USA.
[15]
Tumour Suppression Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. manuel.serrano@irbbarcelona.org.;Cellular Plasticity and Disease Group, Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. manuel.serrano@irbbarcelona.org.;Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. manuel.serrano@irbbarcelona.org.
[16]
DOI
10.1038/s41556-020-0573-1
PMID
32989249
发布时间
2022-10-22
换一批
换一批
